MARIVIC QUINTINITA: Open Payments
NPI 1730381641 · TITUSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 54 payments from 12 companies in 2025. Trend: 2023 $2,599 · 2024 $1,350 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $363 |
| Madrigal Pharmaceuticals | 6 | $133 |
| Janssen Biotech, Inc. | 5 | $112 |
| PFIZER INC. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Ardelyx, Inc. | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Celltrion USA Inc. | 1 | $23 |
| Enterra Medical, Inc. | 1 | $19 |
| EVOKE PHARMA, INC. | 1 | $19 |
Products named: LINZESS, REZDIFFRA, TREMFYA, RINVOQ, ENTYVIO, MAVYRET, IBSRELA, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
